Antioxidants other than vitamin C may be detected by glucose meters: Immediate relevance for patients with disorders targeted by antioxidant therapies.
Antioxidant
COVID-19
Cysteine
Dihydrolipoate
Dithiothreitol
Falsely-elevated glycemia
Glucose meter
Glutathione
Glycemic control
Glycemic mismanagement
Hypoglycemic drug overdoses
N-acetylcysteine
Parkes’ error grid analysis
Points-of-care
Vitamin-C
Journal
Clinical biochemistry
ISSN: 1873-2933
Titre abrégé: Clin Biochem
Pays: United States
ID NLM: 0133660
Informations de publication
Date de publication:
Jun 2021
Jun 2021
Historique:
received:
22
10
2020
revised:
11
03
2021
accepted:
13
03
2021
pubmed:
27
3
2021
medline:
25
5
2021
entrez:
26
3
2021
Statut:
ppublish
Résumé
Owing to their ease of use, glucose meters are frequently used in research and medicine. However, little is known of whether other non-glucose molecules, besides vitamin C, interfere with glucometry. Therefore, we sought to determine whether other antioxidants might behave like vitamin C in causing falsely elevated blood glucose levels, potentially exposing patients to glycemic mismanagement by being administered harmful doses of glucose-lowering drugs. To determine whether various antioxidants can be detected by seven commercial glucose meters, human blood samples were spiked with various antioxidants ex vivo and their effect on the glucose results were assessed by Parkes error grid analysis. Several of the glucose meters demonstrated a positive bias in the glucose measurement of blood samples spiked with vitamin C, N-acetylcysteine, and glutathione. With the most interference-sensitive glucose meter, non-blood solutions of 1 mmol/L N-acetylcysteine, glutathione, cysteine, vitamin C, dihydrolipoate, and dithiothreitol mimicked the results seen on that glucose meter for 0.7, 1.0, 1.2, 2.6, 3.7 and 5.5 mmol/L glucose solutions, respectively. Glucose meter users should be alerted that some of these devices might produce spurious glucose results not only in patients on vitamin C therapy but also in those being administered other antioxidants. As discussed herein, the clinical relevance of the data is immediate in view of the current use of antioxidant therapies for disorders such as the metabolic syndrome, diabetes, cardiovascular diseases, and coronavirus disease 2019.
Identifiants
pubmed: 33766514
pii: S0009-9120(21)00076-X
doi: 10.1016/j.clinbiochem.2021.03.007
pii:
doi:
Substances chimiques
Antioxidants
0
Blood Glucose
0
Glutathione
GAN16C9B8O
Ascorbic Acid
PQ6CK8PD0R
Acetylcysteine
WYQ7N0BPYC
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
71-76Informations de copyright
Copyright © 2021 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.